Shares: Drug cure for depression: Quentin Lumsden prescribes six healthcare stocks set for recovery

IF THE stock market consisted entirely of healthcare stocks, and the way things are going it sometimes seems as though it soon will, investors would have a very different perspective. Instead of a grim bear market they would see a dramatic bull market, which had paused for breath in the first half of 1991 but now seems to be picking up steam again. My guess is that now is a good time to climb aboard once more.

One problem with the leading healthcare stocks is that they are much favoured by institutional investors and tend to have heavyweight share prices.

In terms of its price-earnings ratio, the cheapest of the six international drug shares I have selected for my mini-portfolio is the Swiss group Roche, which is on a prospective p/e for 1993 of under 13, according to the analyst Andrew Tivenen, of James Capel. But one share in Roche costs a jaw-dropping SFr3,380 (pounds 1,368).

Fortunately, heavyweight prices are no bar to a sizzling performance. Roche shares have climbed four-fold from their levels in the mid-1980s. The same goes for the other shares in my selection. Glaxo at 749p is up five-fold; Wellcome, at 826p, is up 6.5 times. The world's leading drug company, Merck, at dollars 48.25 (pounds 24.14), is up 10 times in dollar terms but nearer 5.5 times for sterling-based investors. Pfizer, at dollars 79.62, also based in the US, was a slow starter in the 1980s, but new drugs have boosted it around 2.5 times in sterling. Lastly, the Swedish company Astra, at Kr535 for the 'A' shares, has grown fastest of all: 8.5 times in sterling terms.

The key attraction of these great healthcare companies is their ability to sustain strong growth in earnings despite recession. The analysts at James Capel suggested the following medium-term growth rates for my selection: Glaxo 14 per cent, Wellcome 20 per cent, Merck 18, Pfizer 19, Astra 25-30 and Roche 20. That looks highly attractive in a world where investors are coming to terms with the prospect that the global economy may stay becalmed into the mid-1990s. A big change in this decade is that the pronounced weakness of the dollar is no longer seen as a negative for European drug stocks, even though they all make a substantial proportion of their sales in the US.

One analyst, Paul Woodhouse at Smith New Court, says observation almost suggests these shares flourish when the dollar is weak. This could be because American investors like to buy strong-currency stocks.

Nor are profits as adversely affected as in the past. Wellcome and other companies manufacture in the US so that they do not have the problem of trying to sell into the US from a high-cost base. Glaxo sources heavily from dollar-bloc areas such as Singapore.

Furthermore, manufacturing costs are only about 16 per cent of final selling prices. Twice as important are sales and marketing costs incurred in the US for sales made there.

A combination of investors neglecting drug shares and general gloom in stock markets has made these pharmaceuticals relatively cheap by historic standards. Astra, for example, has a spectacular portfolio of drugs. Its world-beating ulcer preparation, Losec, has overtaken SmithKline's Tagamet and is second only to Glaxo's Zantac. Yet on analyst Andrew Tivenen's estimates, Astra is on a prospective p/e of 16 on 1993 earnings per share, and could well continue to grow rapidly.

Shares in Wellcome, almost equally fast-growing, have been depressed by the huge shares sale, and the p/e for the year to 31 August next could be below 18. These are undemanding valuations for some of the most exciting and reliable growth stocks.

(Photograph omitted)

scienceExcitement from alien hunters at 'evidence' of extraterrestrial life
Life and Style
Customers can get their caffeine fix on the move
food + drink
David Moyes gets soaked
sport Moyes becomes latest manager to take part in the ALS challenge
Life and Style
techCould new invention save millions in healthcare bills?
peopleEnglishman managed quintessential Hollywood restaurant Chasen's
Life and Style
food + drinkHarrods launches gourmet food qualification for staff
Mosul dam was retaken with the help of the US
voicesRobert Fisk: Barack Obama is following the jihadists’ script
Arts and Entertainment
Michael Flatley prepares to bid farewell to the West End stage
danceMichael Flatley hits West End for last time alongside Team GB World champion Alice Upcott
Members and supporters of the lesbian, gay, bisexual, transgender (LGBT) community walk with a rainbow flag during a rally in July
ebooksAn evocation of the conflict through the eyes of those who lived through it
Life and Style
Black Ivory Coffee is made using beans plucked from elephants' waste after ingested by the animals
food + drinkFirm says it has created the "rarest" coffee in the world
Arts and Entertainment
Loaded weapon: drugs have surprise side effects for Scarlett Johansson in Luc Besson’s ‘Lucy’
filmReview: Lucy, Luc Besson's complex thriller
Arts and Entertainment
Jamie T plays live in 2007 before going on hiatus from 2010
arts + entsSinger-songwriter will perform on the Festival Republic Stage
Life and Style
food + drinkThese simple recipes will have you refreshed within minutes
Jermain Defoe got loads of custard
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Business Analyst - Banking - London - £550 - £650

£550 - £650 per day: Orgtel: Business Analyst - Traded Credit Risk - Investmen...

Data Centre Engineer - Linux, Redhat, Solaris, SAN, Puppet

£55000 per annum: Harrington Starr: A financial software vendor at the forefro...

.NET Developer

£600 per day: Harrington Starr: .NET Developer C#, WPF,BLL, MSMQ, SQL, GIT, SQ...

Data Centre Engineer - Linux / Redhat / Solaris / Puppet / SAN

£65000 per annum: Harrington Starr: A financial software vendor at the forefro...

Day In a Page

Air strikes? Talk of God? Obama is following the jihadists’ script

Air strikes? Talk of God? Obama is following the jihadists’ script

The President came the nearest he has come yet to rivalling George W Bush’s gormless reaction to 9/11 , says Robert Fisk
Ebola outbreak: Billy Graham’s son declares righteous war on the virus

Billy Graham’s son declares righteous war on Ebola

A Christian charity’s efforts to save missionaries trapped in Africa by the crisis have been justifiably praised. But doubts remain about its evangelical motives
Jeremy Clarkson 'does not see a problem' with his racist language on Top Gear, says BBC

Not even Jeremy Clarkson is bigger than the BBC, says TV boss

Corporation’s head of television confirms ‘Top Gear’ host was warned about racist language
Nick Clegg the movie: Channel 4 to air Coalition drama showing Lib Dem leader's rise

Nick Clegg the movie

Channel 4 to air Coalition drama showing Lib Dem leader's rise
Philip Larkin: Misogynist, racist, miserable? Or caring, playful man who lived for others?

Philip Larkin: What will survive of him?

Larkin's reputation has taken a knocking. But a new book by James Booth argues that the poet was affectionate, witty, entertaining and kind, as hitherto unseen letters, sketches and 'selfies' reveal
Madame Tussauds has shown off its Beyoncé waxwork in Regent's Park - but why is the tourist attraction still pulling in the crowds?

Waxing lyrical

Madame Tussauds has shown off its Beyoncé waxwork in Regent's Park - but why is the tourist attraction still pulling in the crowds?
Texas forensic astronomer finally pinpoints the exact birth of impressionism

Revealed (to the minute)

The precise time when impressionism was born
From slow-roasted to sugar-cured: how to make the most of the British tomato season

Make the most of British tomatoes

The British crop is at its tastiest and most abundant. Sudi Pigott shares her favourite recipes
10 best men's skincare products

Face it: 10 best men's skincare products

Oscar Quine cleanses, tones and moisturises to find skin-savers blokes will be proud to display on the bathroom shelf
Malky Mackay allegations: Malky Mackay, Iain Moody and another grim day for English football

Mackay, Moody and another grim day for English football

The latest shocking claims do nothing to dispel the image that some in the game on these shores exist in a time warp, laments Sam Wallace
La Liga analysis: Will Barcelona's hopes go out of the window?

Will Barcelona's hopes go out of the window?

Pete Jenson starts his preview of the Spanish season, which begins on Saturday, by explaining how Fifa’s transfer ban will affect the Catalans
Middle East crisis: We know all too much about the cruelty of Isis – but all too little about who they are

We know all too much about the cruelty of Isis – but all too little about who they are

Now Obama has seen the next US reporter to be threatened with beheading, will he blink, asks Robert Fisk
Neanderthals lived alongside humans for centuries, latest study shows

Final resting place of our Neanderthal neighbours revealed

Bones dated to 40,000 years ago show species may have died out in Belgium species co-existed
Scottish independence: The new Scots who hold fate of the UK in their hands

The new Scots who hold fate of the UK in their hands

Scotland’s immigrants are as passionate about the future of their adopted nation as anyone else
Britain's ugliest buildings: Which monstrosities should be nominated for the Dead Prize?

Blight club: Britain's ugliest buildings

Following the architect Cameron Sinclair's introduction of the Dead Prize, an award for ugly buildings, John Rentoul reflects on some of the biggest blots on the UK landscape